CONCURRENT PROGRAMS

August 21-22

August 22-23

Enabling Point-of-Care Diagnostics 

Molecular Diagnostics
for Infectious Disease
 

Emerging Molecular
Markers of Cancer
 

Companion Diagnostics 

Mass Spectrometry in Clinical Diagnostics 

Commercialization of
Molecular Diagnostics
 

Regulatory Compliance in Drug-Diagnostics Co-Development 

 

 


ABOUT THE SUMMIT

Technological advances in next generation diagnostics are driving growth and innovation in healthcare. Rapid and precise diagnosis is essential for personalized medicine and will change the way value is assessed and compensated in the healthcare system. This meeting offers a comprehensive view of the changing landscape of diagnostics and brings together the key players in the field.

The Next Generation Dx Summit (Enabling Point-of-Care Diagnostics, Emerging Molecular Markers of Cancer, Molecular Diagnostics for Infectious Disease, Companion Diagnostics, Commercialization of Molecular Diagnostics, Mass Spec for the Clinic) is designed to bring together all of the major players in the evolving areas of diagnostics. This year, we have assembled an impressive faculty of speakers from industry, government, and leading academic institutions. This meeting will showcase improvements in technology research and development with an emphasis on applications in the clinic and commercialization. Plan to hear what the industry leaders are saying about future market opportunities and network with your peers this August 21-23 in Washington, DC.


EVENT FEATURES

  • Meet all the major players in the evolving area of diagnostics
  • Get a comprehensive view of the changing landscape of diagnostics
  • Network with 500+ global attendees
  • Interactive Plenary Keynote session addressing regulatory bottlenecks
  • Connect with attendees using CHI's Intro-Net
  • Participate in the poster competition
  • Choose from 12 pre-conference short courses
  • View innovative products and novel technologies in the expansive exhibit hall
  • And much more!